Fig. 2
From: DCYTB is a predictor of outcome in breast cancer that functions via iron-independent mechanisms
DCYTB predicts outcome independent of ER and LN status. Kaplan-Meier analysis of patients in cohort #1 subsetted by high and low DCYTB expression and a ER+ (p = 1.3e-10, n = 643), b ER- (p = 0.03, n = 89), c LN+ (p = 1.5e-07, n = 364), d LN- (p = 0.0001, n = 358). DCYTB duodenal cytochrome b, ER estrogen receptor, LN lymph node